Christopher Houle

1.2k total citations
34 papers, 744 citations indexed

About

Christopher Houle is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Christopher Houle has authored 34 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Christopher Houle's work include Computational Drug Discovery Methods (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Christopher Houle is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Christopher Houle collaborates with scholars based in United States, United Kingdom and Canada. Christopher Houle's co-authors include Barbara J. Davis, Jiri Aubrecht, Shelli Schomaker, Jennifer Colangelo, Lina Luo, Julie F. Foley, Cynthia A. Afshari, Xiaoyu Ding, J. Carl Barrett and Elie Needle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Christopher Houle

34 papers receiving 726 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher Houle 297 110 107 98 87 34 744
Marcin Ratajewski 385 1.3× 36 0.3× 43 0.4× 162 1.7× 50 0.6× 51 853
Olga V. Tikhonova 473 1.6× 39 0.4× 31 0.3× 62 0.6× 63 0.7× 80 803
Irena Manov 349 1.2× 92 0.8× 148 1.4× 113 1.2× 127 1.5× 31 829
Chuanxu Liu 470 1.6× 56 0.5× 40 0.4× 84 0.9× 19 0.2× 30 776
Vivek J. Kadambi 1.1k 3.6× 33 0.3× 36 0.3× 145 1.5× 85 1.0× 41 1.7k
Christopher D. Kane 576 1.9× 90 0.8× 13 0.1× 113 1.2× 95 1.1× 31 956
Marina Bessarabova 491 1.7× 106 1.0× 28 0.3× 75 0.8× 34 0.4× 13 697
Andrew Olaharski 354 1.2× 68 0.6× 13 0.1× 111 1.1× 51 0.6× 21 642
Laxmikanth Kollipara 674 2.3× 37 0.3× 21 0.2× 107 1.1× 65 0.7× 40 982
Mohammad Ali 627 2.1× 26 0.2× 81 0.8× 230 2.3× 121 1.4× 32 970

Countries citing papers authored by Christopher Houle

Since Specialization
Citations

This map shows the geographic impact of Christopher Houle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Houle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Houle more than expected).

Fields of papers citing papers by Christopher Houle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Houle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Houle. The network helps show where Christopher Houle may publish in the future.

Co-authorship network of co-authors of Christopher Houle

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Houle. A scholar is included among the top collaborators of Christopher Houle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Houle. Christopher Houle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finley, James E., Anna K. Kopec, Petra Koza‐Taylor, et al.. (2020). An in vitro alveolar epithelial cell model recapitulates LRRK2 inhibitor-induced increases in lamellar body size observed in preclinical models. Toxicology in Vitro. 70. 105012–105012. 6 indexed citations
2.
Pardo, Ingrid D., et al.. (2018). Spontaneous Ectopic Choroid Plexus with Sclerosis in Adult Beagle Dogs. Toxicologic Pathology. 46(5). 608–609. 2 indexed citations
3.
Shah, Falgun, Antonia F. Stepan, Alison O’Mahony, et al.. (2017). Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell chemical biology. 24(7). 858–869.e5. 26 indexed citations
4.
Zuhl, Andrea M., Charles E. Nolan, Michael A. Brodney, et al.. (2016). Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors. Nature Communications. 7(1). 13042–13042. 59 indexed citations
5.
Wu, Hong, et al.. (2016). Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys. Toxicologic Pathology. 45(1). 127–133. 4 indexed citations
6.
Zagadailov, Erin, et al.. (2015). Use Of Work Productivity Endpoints In Clinical Studies: A Review By Disease State And Measurement Type. Value in Health. 18(3). A30–A30. 1 indexed citations
7.
Campion, Sarah N., John Marcek, Steven W. Kumpf, et al.. (2015). Age-related testicular toxicity of mGluR5 negative allosteric modulators appears to be unrelated to testis drug transporter maturity. Reproductive Toxicology. 52. 7–17. 1 indexed citations
8.
Shirai, Norimitsu, Christopher Houle, & Michael Mirsky. (2015). Using Histopathologic Evidence to Differentiate Reproductive Senescence from Xenobiotic Effects in Middle-aged Female Sprague-Dawley Rats. Toxicologic Pathology. 43(8). 1158–1161. 8 indexed citations
9.
Palanisamy, Gopinath S., John Marcek, Gregg D. Cappon, et al.. (2015). Drug-induced Skin Lesions in Cynomolgus Macaques Treated with Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulators. Toxicologic Pathology. 43(7). 995–1003. 8 indexed citations
10.
Henderson, Jaclyn L., Bethany L. Kormos, Matthew M. Hayward, et al.. (2014). Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor. Journal of Medicinal Chemistry. 58(1). 419–432. 140 indexed citations
11.
Galatsis, Paul, Jaclyn L. Henderson, Bethany L. Kormos, et al.. (2014). Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold. Bioorganic & Medicinal Chemistry Letters. 24(17). 4132–4140. 23 indexed citations
12.
Luo, Lina, Shelli Schomaker, Christopher Houle, Jiri Aubrecht, & Jennifer Colangelo. (2013). Evaluation of Serum Bile Acid Profiles as Biomarkers of Liver Injury in Rodents. Toxicological Sciences. 137(1). 12–25. 94 indexed citations
13.
Walker, Don K., John D. Davis, Christopher Houle, I. Gardner, & Rob Webster. (2009). Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations. Xenobiotica. 39(7). 534–543. 10 indexed citations
14.
Bushel, Pierre R., Alexandra N. Heinloth, Lingkang Huang, et al.. (2007). Blood gene expression signatures predict exposure levels. Proceedings of the National Academy of Sciences. 104(46). 18211–18216. 90 indexed citations
15.
16.
Schmiedt, Chad W., Rebecca E. Gompf, Janice M. Bright, et al.. (2006). Cardiovascular Involvement in 8 Dogs with Blastomyces dermatitidis Infection. Journal of Veterinary Internal Medicine. 20(6). 1351–1354. 10 indexed citations
17.
Schmiedt, Chad W., Alfred Μ. Legendre, Rebecca E. Gompf, et al.. (2006). Cardiovascular Involvement in 8 Dogs with Blastomyces Dermatitidis Infection. Journal of Veterinary Internal Medicine. 20(6). 1351–1351. 10 indexed citations
18.
Houle, Christopher, et al.. (2006). Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice. Toxicologic Pathology. 34(6). 752–762. 17 indexed citations
19.
Houle, Christopher, Xiaoyu Ding, Julie F. Foley, et al.. (2002). Loss of Expression and Altered Localization of KAI1 and CD9 Protein Are Associated with Epithelial Ovarian Cancer Progression. Gynecologic Oncology. 86(1). 69–78. 67 indexed citations
20.
Walker, Cheryl L., et al.. (2001). Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis. 22(12). 2049–2052. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Ratajewski Breakdown of academic impact, for papers by Olga V. Tikhonova Breakdown of academic impact, for papers by Irena Manov Breakdown of academic impact, for papers by Chuanxu Liu Breakdown of academic impact, for papers by Vivek J. Kadambi Breakdown of academic impact, for papers by Christopher D. Kane Breakdown of academic impact, for papers by Marina Bessarabova Breakdown of academic impact, for papers by Andrew Olaharski Breakdown of academic impact, for papers by Laxmikanth Kollipara Breakdown of academic impact, for papers by Mohammad Ali
Rankless by CCL
2026